Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pre-Eclampsia | 6 | 2019 | 53 | 2.430 |
Why?
|
| Placenta | 4 | 2018 | 63 | 2.120 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2019 | 100 | 1.720 |
Why?
|
| Angiotensin I | 7 | 2016 | 262 | 1.700 |
Why?
|
| Uterus | 4 | 2016 | 73 | 1.600 |
Why?
|
| Peptide Fragments | 7 | 2016 | 422 | 1.580 |
Why?
|
| Oxidative Stress | 5 | 2019 | 223 | 1.490 |
Why?
|
| Kidney | 9 | 2015 | 486 | 1.470 |
Why?
|
| Renin | 9 | 2015 | 112 | 1.370 |
Why?
|
| Pregnancy | 13 | 2019 | 815 | 1.210 |
Why?
|
| Rats | 19 | 2019 | 1604 | 1.160 |
Why?
|
| Peptidyl-Dipeptidase A | 6 | 2015 | 142 | 1.140 |
Why?
|
| Blood Pressure | 11 | 2016 | 806 | 1.080 |
Why?
|
| Hypertension | 6 | 2017 | 910 | 1.040 |
Why?
|
| Animals | 24 | 2019 | 7299 | 0.850 |
Why?
|
| Uterine Artery | 3 | 2015 | 4 | 0.800 |
Why?
|
| Pseudopregnancy | 3 | 2016 | 4 | 0.750 |
Why?
|
| Oxygen | 2 | 2017 | 139 | 0.720 |
Why?
|
| Microcirculation | 2 | 2016 | 61 | 0.710 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2019 | 747 | 0.680 |
Why?
|
| Hemodynamics | 1 | 2019 | 148 | 0.660 |
Why?
|
| Sodium Chloride, Dietary | 4 | 2012 | 29 | 0.650 |
Why?
|
| Female | 24 | 2019 | 18173 | 0.640 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2015 | 17 | 0.630 |
Why?
|
| Endocannabinoids | 2 | 2015 | 34 | 0.630 |
Why?
|
| Down-Regulation | 2 | 2015 | 143 | 0.620 |
Why?
|
| Ovariectomy | 4 | 2008 | 147 | 0.610 |
Why?
|
| Embryo Implantation | 2 | 2015 | 35 | 0.600 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 1 | 2016 | 3 | 0.590 |
Why?
|
| Dinoprostone | 1 | 2016 | 37 | 0.580 |
Why?
|
| Femoral Artery | 1 | 2016 | 44 | 0.580 |
Why?
|
| Erythropoietin | 3 | 2015 | 29 | 0.570 |
Why?
|
| Angiotensin II | 7 | 2015 | 279 | 0.560 |
Why?
|
| Amidohydrolases | 2 | 2015 | 8 | 0.550 |
Why?
|
| Disease Models, Animal | 7 | 2019 | 980 | 0.550 |
Why?
|
| Chorionic Villi | 1 | 2015 | 7 | 0.550 |
Why?
|
| Umbilical Cord | 1 | 2015 | 8 | 0.530 |
Why?
|
| Ultrasonography | 1 | 2018 | 345 | 0.530 |
Why?
|
| Monoacylglycerol Lipases | 1 | 2015 | 5 | 0.520 |
Why?
|
| Receptors, Cannabinoid | 1 | 2015 | 26 | 0.520 |
Why?
|
| Nitric Oxide Synthase Type I | 2 | 2012 | 17 | 0.510 |
Why?
|
| MicroRNAs | 1 | 2017 | 173 | 0.500 |
Why?
|
| Rats, Inbred Lew | 8 | 2012 | 116 | 0.500 |
Why?
|
| RNA, Messenger | 6 | 2015 | 514 | 0.490 |
Why?
|
| Antihypertensive Agents | 1 | 2016 | 342 | 0.460 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2013 | 23 | 0.460 |
Why?
|
| Receptors, Angiotensin | 1 | 2013 | 77 | 0.450 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2013 | 75 | 0.450 |
Why?
|
| Ornithine | 1 | 2012 | 4 | 0.440 |
Why?
|
| Estrogens | 3 | 2008 | 162 | 0.430 |
Why?
|
| Muscle, Skeletal | 1 | 2016 | 494 | 0.420 |
Why?
|
| Inflammation | 2 | 2012 | 507 | 0.410 |
Why?
|
| Reperfusion Injury | 1 | 2012 | 43 | 0.410 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2012 | 51 | 0.410 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2015 | 83 | 0.410 |
Why?
|
| Mice, Inbred C57BL | 4 | 2018 | 711 | 0.390 |
Why?
|
| Fetal Growth Retardation | 3 | 2017 | 17 | 0.390 |
Why?
|
| Kidney Failure, Chronic | 2 | 2012 | 518 | 0.380 |
Why?
|
| Decidua | 3 | 2016 | 17 | 0.380 |
Why?
|
| Kidney Diseases | 3 | 2012 | 239 | 0.350 |
Why?
|
| Nitric Oxide Synthase | 1 | 2006 | 36 | 0.290 |
Why?
|
| Mice, Knockout | 3 | 2017 | 425 | 0.280 |
Why?
|
| Renin-Angiotensin System | 5 | 2012 | 182 | 0.270 |
Why?
|
| Regional Blood Flow | 2 | 2016 | 82 | 0.270 |
Why?
|
| Rats, Transgenic | 3 | 2019 | 52 | 0.240 |
Why?
|
| Mice | 5 | 2017 | 2370 | 0.240 |
Why?
|
| Pregnancy, Animal | 2 | 2014 | 19 | 0.230 |
Why?
|
| Angiotensinogen | 2 | 2019 | 73 | 0.200 |
Why?
|
| Blotting, Western | 2 | 2012 | 281 | 0.200 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2012 | 37 | 0.180 |
Why?
|
| Nitrates | 2 | 2012 | 25 | 0.180 |
Why?
|
| Proteinuria | 2 | 2011 | 57 | 0.180 |
Why?
|
| Nitric Oxide | 2 | 2012 | 116 | 0.170 |
Why?
|
| C-Reactive Protein | 2 | 2012 | 232 | 0.170 |
Why?
|
| Humans | 8 | 2017 | 29119 | 0.170 |
Why?
|
| Glycerides | 2 | 2015 | 13 | 0.160 |
Why?
|
| Arachidonic Acids | 2 | 2015 | 23 | 0.160 |
Why?
|
| Young Adult | 2 | 2015 | 2402 | 0.160 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 519 | 0.160 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2017 | 18 | 0.160 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 22 | 0.150 |
Why?
|
| Fetus | 1 | 2018 | 78 | 0.150 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2018 | 130 | 0.150 |
Why?
|
| Oximetry | 1 | 2016 | 28 | 0.150 |
Why?
|
| Pyrrolidonecarboxylic Acid | 1 | 2015 | 5 | 0.140 |
Why?
|
| Myocardial Ischemia | 1 | 2016 | 83 | 0.140 |
Why?
|
| Protein Precursors | 1 | 2015 | 22 | 0.140 |
Why?
|
| Protein Isoforms | 1 | 2015 | 56 | 0.130 |
Why?
|
| Tissue Culture Techniques | 1 | 2015 | 40 | 0.130 |
Why?
|
| Placental Circulation | 1 | 2015 | 1 | 0.130 |
Why?
|
| Rats, Nude | 2 | 2012 | 38 | 0.130 |
Why?
|
| Male | 6 | 2016 | 17815 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 68 | 0.130 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2015 | 68 | 0.130 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2015 | 72 | 0.130 |
Why?
|
| Blood Flow Velocity | 1 | 2015 | 59 | 0.130 |
Why?
|
| Infusion Pumps | 1 | 2015 | 5 | 0.130 |
Why?
|
| Superoxides | 1 | 2015 | 17 | 0.130 |
Why?
|
| Endopeptidases | 1 | 2015 | 26 | 0.130 |
Why?
|
| Collagen | 2 | 2015 | 217 | 0.130 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2014 | 10 | 0.120 |
Why?
|
| Cardiac Output | 1 | 2014 | 32 | 0.120 |
Why?
|
| Vascular Resistance | 1 | 2014 | 28 | 0.120 |
Why?
|
| Vasoconstriction | 1 | 2014 | 40 | 0.120 |
Why?
|
| Forearm | 1 | 2014 | 33 | 0.120 |
Why?
|
| Up-Regulation | 1 | 2015 | 183 | 0.120 |
Why?
|
| Myometrium | 1 | 2013 | 11 | 0.120 |
Why?
|
| Gestational Age | 1 | 2013 | 96 | 0.110 |
Why?
|
| Aldosterone | 3 | 2008 | 28 | 0.110 |
Why?
|
| Biopterin | 1 | 2012 | 3 | 0.110 |
Why?
|
| Nitrites | 1 | 2012 | 20 | 0.110 |
Why?
|
| Anemia | 1 | 2012 | 55 | 0.110 |
Why?
|
| Mutation | 1 | 2015 | 466 | 0.110 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2012 | 22 | 0.110 |
Why?
|
| Fibrosis | 2 | 2015 | 103 | 0.110 |
Why?
|
| Neprilysin | 1 | 2012 | 32 | 0.110 |
Why?
|
| Adult | 2 | 2015 | 8425 | 0.110 |
Why?
|
| Blastocyst | 1 | 2011 | 8 | 0.110 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 93 | 0.100 |
Why?
|
| Fetal Weight | 1 | 2011 | 5 | 0.100 |
Why?
|
| Case-Control Studies | 1 | 2014 | 859 | 0.100 |
Why?
|
| Cell Separation | 1 | 2012 | 86 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 248 | 0.100 |
Why?
|
| Gene Expression | 1 | 2013 | 332 | 0.100 |
Why?
|
| Antigens, CD | 1 | 2012 | 100 | 0.100 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2012 | 71 | 0.100 |
Why?
|
| Cell Transplantation | 1 | 2012 | 63 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2012 | 481 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 103 | 0.100 |
Why?
|
| Muscle Contraction | 1 | 2012 | 114 | 0.100 |
Why?
|
| Models, Animal | 2 | 2011 | 160 | 0.100 |
Why?
|
| Sex Characteristics | 1 | 2012 | 167 | 0.100 |
Why?
|
| Isoenzymes | 2 | 2011 | 63 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2011 | 89 | 0.100 |
Why?
|
| Pregnancy Complications | 1 | 2011 | 80 | 0.100 |
Why?
|
| Heart Failure | 1 | 2016 | 571 | 0.100 |
Why?
|
| Cell Proliferation | 1 | 2012 | 573 | 0.090 |
Why?
|
| Sodium Chloride | 1 | 2008 | 24 | 0.080 |
Why?
|
| Animals, Congenic | 1 | 2007 | 14 | 0.080 |
Why?
|
| Diastole | 1 | 2008 | 90 | 0.080 |
Why?
|
| Hypertrophy | 1 | 2007 | 26 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 1 | 2007 | 45 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2007 | 72 | 0.080 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2008 | 136 | 0.070 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2007 | 80 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2006 | 12 | 0.070 |
Why?
|
| Immunoblotting | 1 | 2006 | 50 | 0.070 |
Why?
|
| Kidney Cortex | 1 | 2006 | 25 | 0.070 |
Why?
|
| Kidney Medulla | 1 | 2006 | 29 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 162 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2007 | 256 | 0.070 |
Why?
|
| Age Factors | 1 | 2008 | 1108 | 0.060 |
Why?
|
| Aging | 1 | 2007 | 881 | 0.050 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2015 | 271 | 0.050 |
Why?
|
| Middle Aged | 1 | 2012 | 10834 | 0.040 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2015 | 31 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2015 | 47 | 0.030 |
Why?
|
| Monoglycerides | 1 | 2014 | 2 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2015 | 66 | 0.030 |
Why?
|
| Polyunsaturated Alkamides | 1 | 2014 | 9 | 0.030 |
Why?
|
| Benzodioxoles | 1 | 2014 | 6 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2014 | 38 | 0.030 |
Why?
|
| Carbamates | 1 | 2014 | 14 | 0.030 |
Why?
|
| Creatinine | 1 | 2015 | 174 | 0.030 |
Why?
|
| Benzamides | 1 | 2014 | 54 | 0.030 |
Why?
|
| Phenotype | 1 | 2015 | 629 | 0.030 |
Why?
|
| Piperidines | 1 | 2014 | 125 | 0.030 |
Why?
|
| Apoptosis | 1 | 2015 | 337 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2012 | 39 | 0.030 |
Why?
|
| Absorption | 1 | 2012 | 15 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2011 | 14 | 0.030 |
Why?
|
| Albumins | 1 | 2012 | 38 | 0.030 |
Why?
|
| Bioartificial Organs | 1 | 2012 | 25 | 0.030 |
Why?
|
| Kidney Tubules | 1 | 2012 | 25 | 0.030 |
Why?
|
| Protein Transport | 1 | 2011 | 74 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 121 | 0.030 |
Why?
|
| Mesenteric Arteries | 1 | 2011 | 18 | 0.030 |
Why?
|
| Fetal Development | 1 | 2011 | 25 | 0.030 |
Why?
|
| Cyclopentanes | 1 | 2011 | 17 | 0.030 |
Why?
|
| Quinolines | 1 | 2011 | 27 | 0.030 |
Why?
|
| Transfection | 1 | 2012 | 192 | 0.030 |
Why?
|
| Sodium, Dietary | 1 | 2011 | 24 | 0.030 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2011 | 39 | 0.030 |
Why?
|
| Reference Values | 1 | 2011 | 224 | 0.020 |
Why?
|
| Random Allocation | 1 | 2011 | 213 | 0.020 |
Why?
|
| Cell Movement | 1 | 2012 | 161 | 0.020 |
Why?
|
| Vasodilation | 1 | 2011 | 87 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2012 | 165 | 0.020 |
Why?
|
| Estradiol | 1 | 2011 | 118 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2012 | 799 | 0.020 |
Why?
|
| Models, Biological | 1 | 2011 | 373 | 0.020 |
Why?
|
| Tissue Scaffolds | 1 | 2012 | 386 | 0.020 |
Why?
|
| Heart Failure, Diastolic | 1 | 2008 | 15 | 0.020 |
Why?
|
| Cardiomegaly | 1 | 2006 | 30 | 0.020 |
Why?
|
| Heart Rate | 1 | 2006 | 315 | 0.020 |
Why?
|
| Risk Factors | 1 | 2011 | 3537 | 0.010 |
Why?
|